APOTHÉCURE WEBRX

Serial Number 85914220
602

Registration Progress

Application Filed
Apr 25, 2013
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: APOTHÉCURE WEBRX
Previous Owner: Apothecure, Inc.
Classes: 035

Trademark Image

APOTHÉCURE WEBRX

Basic Information

Serial Number
85914220
Filing Date
April 25, 2013
Abandonment Date
February 20, 2014
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Mar 18, 2014
Classes
035

Rights Holder

Apothecure, Inc.

03
Address
4001 McEwen Rd, Ste 100
Dallas, TX 75244

Ownership History

Apothecure, Inc.

Original Applicant
03
Dallas, TX

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

11 events
Date Code Type Description Documents
May 23, 2019 WOAG I WITHDRAWAL OF ATTORNEY GRANTED Loading...
May 23, 2019 WOAR I TEAS WITHDRAWAL OF ATTORNEY RECEIVED Loading...
Mar 19, 2014 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Mar 18, 2014 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Aug 19, 2013 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 19, 2013 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 19, 2013 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 13, 2013 DOCK D ASSIGNED TO EXAMINER Loading...
May 3, 2013 MPMK E NOTICE OF PSEUDO MARK E-MAILED Loading...
May 2, 2013 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 29, 2013 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Online distributorship services in the field of pharmaceuticals
First Use Anywhere: May 10, 2010
First Use in Commerce: Jun 1, 2010

Additional Information

Pseudo Mark
APOTHECARY CURE WEB RX

Classification

International Classes
035

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"WEBRX"